Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,544Revenue (TTM) $M8,173Net Margin (%)1.0Altman Z-Score1.5
Enterprise Value $M37,732EPS (TTM) $0.1Operating Margin %0.4Piotroski F-Score7
P/E(ttm)398Beneish M-Score-2.6Pre-tax Margin (%)-3.1Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow59.5y-y EBITDA Growth Rate %--ROA % (ttm)0.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)1.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,362ROIC % (ttm)2.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMichael Price 2016-09-30 Reduce-0.62%$23.11 - $24.48
($23.86)
$ 23.900%Reduce -22.22%700,000
BSXVanguard Health Care Fund 2016-09-30 Reduce-0.35%$23.11 - $24.48
($23.86)
$ 23.900%Reduce -13.24%46,520,049
BSXJohn Paulson 2016-09-30 Add0.08%$23.11 - $24.48
($23.86)
$ 23.900%Add 336.17%410,000
BSXDodge & Cox 2016-09-30 Reduce$23.11 - $24.48
($23.86)
$ 23.900%Reduce -0.73%382,130
BSXMario Gabelli 2016-09-30 Reduce$23.11 - $24.48
($23.86)
$ 23.900%Reduce -2.14%673,046
BSXMichael Price 2016-06-30 Reduce-2.22%$18.81 - $23.37
($21.59)
$ 23.9011%Reduce -48.28%900,000
BSXVanguard Health Care Fund 2016-06-30 Reduce-0.4%$18.81 - $23.37
($21.59)
$ 23.9011%Reduce -15.19%53,619,190
BSXMario Gabelli 2016-06-30 Reduce-0.01%$18.81 - $23.37
($21.59)
$ 23.9011%Reduce -13.60%687,746
BSXJohn Paulson 2016-06-30 Add$18.81 - $23.37
($21.59)
$ 23.9011%Add 27.03%94,000
BSXDodge & Cox 2016-06-30 Reduce$18.81 - $23.37
($21.59)
$ 23.9011%Reduce -9.94%384,930
BSXMichael Price 2016-03-31 Reduce-0.55%$16.07 - $18.82
($17.57)
$ 23.9036%Reduce -12.12%1,740,000
BSXVanguard Health Care Fund 2016-03-31 Reduce-0.03%$16.07 - $18.82
($17.57)
$ 23.9036%Reduce -1.38%63,222,390
BSXJohn Paulson 2016-03-31 Buy 0.01%$16.07 - $18.82
($17.57)
$ 23.9036%New holding74,000
BSXDodge & Cox 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 23.9036%Reduce -5.19%427,430
BSXMario Gabelli 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 23.9036%Reduce -3.13%796,046
BSXDodge & Cox 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 23.9033%Reduce -4.68%450,830
BSXMario Gabelli 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 23.9033%Reduce -2.96%821,746
BSXVanguard Health Care Fund 2015-09-30 Add0.16%$15.78 - $18.02
($17.1)
$ 23.9040%Add 7.52%64,108,690
BSXMario Gabelli 2015-09-30 Reduce-0.01%$15.78 - $18.02
($17.1)
$ 23.9040%Reduce -12.09%846,846
BSXDodge & Cox 2015-09-30 Reduce$15.78 - $18.02
($17.1)
$ 23.9040%Reduce -19.60%472,960
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pierce David ASVP and President, Endoscopy 2017-01-09Sell10,232$22.247.46view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2017-01-09Sell6,195$22.247.46view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-12-01Sell26,726$20.4816.7view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-11-01Sell24,752$21.899.18view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-09-01Sell24,074$24.1-0.83view
Sorenson John BradleySVP, Manuf & Sup Chn 2016-08-11Sell2,500$23.90view
Mahoney Michael FPresident & CEO 2016-08-01Sell44,400$24.44-2.21view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-08-01Sell24,000$24.46-2.29view
Pierce David ASVP and President, Endoscopy 2016-07-20Sell2,480$24.03-0.54view
Phalen Michael P.EVP & President, MedSurg 2016-07-20Sell35,000$24.03-0.54view

Press Releases about BSX :

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
John Paulson Continues to Buy These 8 Stocks Dec 23 2016 
Medtronic Misses 2nd Quarter Revenue Expectations Nov 27 2016 
Michael Price Sells Dolby Labs, EMC Nov 21 2016 
Vanguard Health Care Fund Sells Amgen, Baxter Nov 02 2016 
Michael Price Trims Boston Scientific, Buys Outerwall Aug 23 2016 
Eaton Vance Worldwide Health Sciences Fund 2nd Quarter Commentary Aug 04 2016 
Vanguard Sold Shares in 7 of Top 10 Quarterly Transactions Aug 02 2016 
Sam Isaly's Top Investments of the Year Aug 01 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific, Sonic, HealthEquity Apr 10 2016 

More From Other Websites
BOSTON SCIENTIFIC CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 20 2017
Will Boston Scientific (BSX) Pull a Surprise in Q4 Earnings? Jan 19 2017
Boston Scientific Charts Appear Boston Strong Jan 11 2017
Parkinson’s Therapy Gets Fresh Look From Device Makers Jan 08 2017
Parkinson's Therapy Gets Fresh Look From Device Makers Jan 08 2017
Medtronic Downgraded On Increased Boston, J&J, St. Jude Rivalries Jan 03 2017
Boston Scientific To Webcast Conference Call Discussing Fourth Quarter 2016 Financial Results And... Jan 03 2017
Boston Scientific To Webcast Conference Call Discussing Fourth Quarter 2016 Financial Results And... Jan 03 2017
St. Jude’s Proclaim Elite SCS System Received CE Mark Approval Dec 30 2016
Boston Scientific To Participate In 35th Annual J.P. Morgan Healthcare Conference Dec 30 2016
Boston Scientific, Google look to jumpstart digital health startups Dec 29 2016
Boston Scientific Corp. – Value Analysis (NYSE:BSX) : December 27, 2016 Dec 27 2016
Boston Scientific Down on Risks; Innovations Raise Hope Dec 27 2016
Boston Scientific Corp. breached its 50 day moving average in a Bullish Manner : BSX-US : December... Dec 23 2016
These Billionaire Michael Price’s Stock Picks Can Destroy Your Portfolio Dec 22 2016
Boston Scientific Acquires Neovasc to Boost Heart Business Dec 14 2016
[$$] Is Boston Scientific Nervous About Nevro? Dec 13 2016
Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common... Dec 13 2016
Neovasc and Boston Scientific Close US$75 Million Agreement Dec 13 2016
Nevro Announces Filing of Lawsuit by Boston Scientific Dec 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)